Journal
ONCOTARGET
Volume 7, Issue 20, Pages 29063-29080Publisher
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.8666
Keywords
TRPM8; ER calcium fluxes; mitochondria; prostate cancer; apoptosis
Categories
Funding
- INSERM
- Ministere de l'Education Nationale
- Ligue Nationale Contre le Cancer
- Region Nord-Pas-de-Calais
- Agence Nationale de Recherche
- Association de Recherche sur les Tumeurs de la Prostate
- fondation pour la recherche medicale
Ask authors/readers for more resources
Since its cloning a decade ago, TRPM8 channel has emerged as a promising prognostic marker and a putative therapeutic target in prostate cancer (PCa). However, recent studies have brought to light the complexity of TRPM8 isoforms in PCa. Consequently, the respective role of each TRPM8 isoform needs to be deciphered prior to considering TRPM8 as an attractive therapeutic target. Full-length (6 transmembrane (TM)-domain) TRPM8 channel is overexpressed in early PCa and repressed in advanced prostate tumors whereas the localization of the truncated, 4TM-TRPM8 channel (4 transmembrane (TM)-domain), in the membranes of endoplasmic reticulum (ER) is independent of the pathogenic status of epithelial cells. In the same line, expression of non-channel cytoplasmic small TRPM8 isoforms (namely sM8) is conserved in cancer cells. In this study, we identify sM8s as putative regulator of PCa cell death. Indeed, suppression of sM8 isoforms was found to induce concomitantly ER stress, oxidative stress, p21 expression and apoptosis in human epithelial prostate cancer cells. We furthermore demonstrate that induction of such mechanisms required the activity of 4TM-TRPM8 channels at the ER-mitochondria junction. Our study thus suggests that targeting sM8 could be an appropriate strategy to fight prostate cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available